Completed

NCT Number: NCT01115959

Seizures Post Intracerebral Hemorrhage

This study examines early antiepileptic treatment with valproic acid for acute cerebral hemorrhage against a placebo group immediately post event to evaluate the outcome of these patients regarding seizures and neurological outcome.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Post Cerebral Hemorrhage

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

cerebral hemorrhage spontaneous

Exclusion criteria

early seizures

Treatment and study plan

Valproic acid

Drug

treatment of 1 month dosage of 400 mg BID

placebo bid

Drug

Primary outcomes

number of seizures

Time frame: study drug for 1 month and 1 year follow up

Secondary outcomes

neurological outcome NIHSS

Time frame: during 1 month study drug and 1 year post follow up

Sponsors and collaborators

Lead sponsor

Wolfson Medical Center

Other Gov

Registry information

Official study title

Are Post Intracerebal Hemorrhage Prevented By Anti-Epileptic Treatment?

Important dates

Study start: 2003
Primary completion: 2008
Study completion: 2008
First posted: May 4, 2010
Registry last updated: Jun 12, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.